Selected proceedings of the 2010 Summit on Translational Bioinformatics by Mendonça, Eneida A & Tarczy-Hornoch, Peter
INTRODUCTION Open Access
Selected proceedings of the 2010 Summit on
Translational Bioinformatics
Eneida A Mendonça
1*†, Peter Tarczy-Hornoch
2†
From 2010 AMIA Summit on Translational Bioinformatics
San Francisco, CA, USA. 10-12 March 2010
Background
The third AMIA Summit on Translational Bioinformatics
built on the success of the 2008 and 2009 Summits. The
Summit continues to highlight the multidisciplinary nat-
ure of this rapidly maturing research field and provides
the opportunity to forge new transdisciplinary collabora-
tions as the finest minds of the academia, industry, gov-
ernment and non-profit sector are brought together. The
six tracks spanned the range from methods for the ana-
lyses of molecular through clinical measurements and
informatics methods in genetics discoveries and clinical
practice.
1: Informatics Methods for the Integrative Analysis of
Molecular and Clinical Measurements
2: Computational Approaches to Finding Molecular
Mechanisms and Therapies for Disease
3: Informatics Concepts, Tools, and Techniques to
Enable Integrative Translational Bioinformatics Research
4: Relating and Representing Phenotypes and Disease
for Translational Bioinformatics Research
5: Informatics Methods Bridging Genetics Discoveries
and Clinical Practice
6: Dissecting Disease through the Study of Organisms,
Evolution, and Taxonomy
Overview of the 2010 Summit
The breadth and depth of the Summit continues to
grow with twenty-five 90-minute scientific sessions. Ori-
ginal research was presented in forty-nine papers and
abstract presentations covering all six tracks and span-
ning from methods to applications. Ten late breaking
sessions covered work in press or published since the
2009 Summit including for example a presentation of
the analysis of a full human genome in the clinical con-
text. Six of the seven National Centers for Biomedical
Computing presented on the relationship of their work
to the themes of the Summit along with five other
panels covering topics ranging from CTSAs to the
eMERGE network. Four keynote presentations addressed
the theme of paths toward genomic medicine. Spyro
Mousses of TGen presented on “Using BioIntelligence
to Search and Understand Individual Genomes” illu-
strated the ideas in the context of individualized cancer
therapy. Serge Saxonov of 23andMe presented on “Con-
sumers, Genomes and Research” demonstrating how
this approach could replicate findings from other studies
and contribute to new genomic knowledge. Andrew
Kasarskis of Sage Bionetwork presented on “Getting
from Heterogeneous Data to Actionable Shared Models
of Biology” and how these approaches can advance our
fundamental understand of the underlying biology.
Finally in what has become an annual tradition Russ
Altman of Stanford presented a recap of some key
developments and papers in his “Translational Bioinfor-
matics Year in Review”.
Slides from selected tutorials, papers, and panels are
publicly available at http://summit2010.amia.org/session-
details.
Summary of selected contributions
The eleven papers selected for this supplement to BMC
Bioinformatics are extended and improved versions of
the best papers accepted to the 2010 Summit on Trans-
lational Bioinformatics. These papers were nominated
by members of the Scientific Program Committee and
the Track Chairs and then subject to revision and addi-
tional peer review in collaboration with BMC Bioinfor-
matics. These papers illustrate the span of the Summit
and range from bioinformatics approaches to new
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the application of this type of knowledge. In the follow-
ing paragraphs we present an overview of the papers in
this special issue and their organization.
We start with three papers that describe original
informatics methods for the integrative analysis of mole-
cular and clinical measurements. The first paper deals
with representing temporal processes in biology, while
the other two deal with reasoning across molecular and
clinical measurements. Chang and colleagues [1]
describe a methodology to identify expression quantita-
tive trait loci (eQTLs) using an information theory
approach. The method is used to create transcriptional
information maps (TIM). The authors illustrated by
constructing a TIM of pediatric lymphoblastic leukemia.
Payne et al. [2] reports on an integrative approach that
b r i d g e sn e t w o r k so fb i o - m o l e c u l a ra n dp h e n o t y p i c
networks with diagnose and treatment of diseases. The
article presents a series of experiments that utilize
multi-modal approaches to network induction. The
authors performed the experiments using data from the
National Cancer Institute (NCI) funded Chronic Lym-
phocytic Research Consortium. Based on the experiment
results, the authors propose a conceptual model that
aims to identify novel and knowledge-anchored biomar-
ker-phenotype complexes. The last article in this group,
by Chen et al [3], proposes a vector-based representa-
tion of patient clinical biomarkers to search for latent
physiological factors that underlie human diseases
directly from clinical laboratory data. The authors ana-
lyse factors for five chronic conditions and demonstrate
that their methodology is able to offer new insights into
the pathophysiological basis of human disease.
One article focuses on computational approaches to
finding molecular mechanisms and therapies for disease.
More specifically, Zhang and collaborators [4] investi-
gate the use of gene co-expression network analysis to
identify potential biomarkers for chronic lymphocytic
leukemia. The authors utilize microarray datasets corre-
sponding to multiple types of cancer from the Gene
Expression Omnibus and the CODENSE algorithm to
identify highly connected gene co-expression networks
in which ZAP70, a well characterized biomarker for
chronic lymphocytic leukemia (CLL). In the experiment,
they were able to identify a new set of genes, which are
potential CLL prognostic biomarkers.
The next two articles discuss techniques to enable
integrative translational research. The paper by Morgan
et al. [5] discuss the differences between meta analysis
techniques and how these techniques may be used
together with real data to understand a biomedical pro-
blem with clinical implications. The work focuses on the
application of some of the traditional approaches to
meta analysis applied to multiplex gene expression data.
Their results show that there is a value in doing meta
analysis and combining results from different studies.
However, not all techniques p e r f o r ma tt h es a m el e v e l
of improvement. Harpaz and collaborators [6] demon-
strate the feasibility of using language processing and
mining techniques (association rule mining) to identify
multi-item adverse drug event associations in the Food
and Drug Administration’s spontaneous adverse event
reporting system. The paper discussed the limitations
and challenges that can be attributed to both the
method and the quality of the data, and the develop-
ment of a taxonomy based on the associations identified.
The paper that follows is in the area of representing
phenotypes and disease for translational bioinformatics
research. The study by Lacson et al. [7] assesses the ade-
quacy of documented asthma markers in the Gene
Expression Omnibus database (GEO). They report on
918 asthma samples with 20,640 annotated markers.
The analyses show a inadequate variable coverage within
GEO and a inconsistent use of terms, although the asso-
ciation between variables was adequate.
Two papers focus on the important topic of infor-
matics methods bridging genetics discoveries and clini-
cal practice. Tatonetti and collaborators [8] describe a
new method for candidate pharmacogene discovery
from pharmacogenomics genome-wide association stu-
dies (GWAS). The new method proposes a knowledge
integration and SNP aggregation approach for indentify-
ing genes impacting drug response. For the applied
domain, application of warfarin dosing, the method was
able to improve the results from a GWAS study, identi-
fying a second pharmacogene. In addition, it was able to
discriminate between low-dose and high-dose respon-
ders. The work serves as a foundation for future predic-
tive pharmacogenomics. The study by Overby et al. [9]
focuses on incorporating genomic knowledge into elec-
tronic medical records for pharmacogenomic clinical
decision support. The authors assess the feasibility of
incorporating pharmacogenomic information knowledge
resources (e.g., PharmGKB, FDA approved drug labels,
biomedical literature) with clinical relevant knowledge
to support decision-making. The paper presents an ana-
lysis of the availability of clinically relevant knowledge in
the selected resources, as well as an analysis of the avail-
ability of computable patient data for pharmacoge-
nomics decision-making.
Finally, the last two papers present research work in
the area of dissecting disease through the study of
organisms, evolution, and taxonomy. The paper by
Yang et al. [10] focuses on animal models and human
diseases. The authors propose to elucidate stromal
microenvironment signals from probes on human
arrays unintentionally cross-hybridizing with mouse
homologous genes in xenograph tumor models. A
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the tumor stromal microenvironment, called “biologi-
cal component analysis” is presented and evaluated.
The model enriches the gene expression signals in the
stromal component separately from the cancer cell
component of the tumor xenograft, allowing research-
ers to better characterize the tumor microenvironment
without additional costs. Rouchka and collaborators
[11] focus the work on genome sequence repeats and
disease. The authors present an analysis of newly
released data fro the 1000 Genomes project with the
goal to detect previously unreported full length inser-
tions of the retrotransposonL I N E - 1 .T h er e s u l t ss u g -
gest that the next generation sequencing data can
potentially help in the assessment of the amount of
heterogeneity with respect to the LINE-1 retrotranspo-
son amongst humans. It also presents new perspectives
for testable hypotheses on the impact that this diver-
sity may have on health individuals.
Dedication
The authors and AMIA would like to dedicate this spe-
cial issue to Marco Ramoni who played a vital role in
the establishment of the AMIA Summit on Transla-
tional Bioinformatics having served as Track Chair for
the 2008 and 2009 Summits and having served as a
member of the Scientific Program Committee for the
2010 Summit. Prior to his sudden passing on June 8,
2010 Marco was one of the leading lights of the young
field of translational bioinformatics. Marco was an
Associate Professor of Pediatrics and Medicine at Har-
vard Medical School and research faculty at Children’s
Hospital, Boston and Brigham and Women’sH o s p i t a l .
Most recently he was the Director, Biomedical Cyber-
netics Laboratory, Harvard Medical School, Director,
NLM Fellowship in Biomedical Informatics, Children’s
Hospital Informatics Program., and Associate Director
of Bioinformatics, Harvard - Partners Center for Genet-
ics and Genomics. He was also the Director of the
course “Biomedical Informatics” at the Harvard-MIT
Division of Health Sciences and Technology, core
faculty of the course Genomic Medicine at Harvard
Medical School and a member of the curriculum com-
mittee of the Cellular and Molecular Medicine track of
the Medical Physics and Medical Engineering graduate
program at Harvard-MIT Division of Health Sciences
and Technology. He was co-founder of Bayesware LLC,
a software company developing machine-learning pro-
grams based on Bayesian methods. He received a PhD
in Biomedical Engineering and a BA in Philosophy
(Epistemology) from the University of Pavia (Italy) and
his postdoctoral training from McGill University, Mon-
treal (Canada). He held academic and visiting positions
at the University of Massachusetts, the University of
London (United Kingdom), the Knowledge Media Insti-
tute (United Kingdom), and the University of Geneva
(Switzerland). He is author of well over 100 publications
in genetics, biomedical informatics, statistics and artifi-
cial intelligence.
Acknowledgements
Text The 2010 Summit on Translational Bioinformatics, held 10–12 March
2010 in San Francisco, CA, USA, was sponsored by the American Medical
Informatics Association (AMIA), and co-sponsored by the International
Society for Computational Biology (ISCB). We thank all the authors who
submitted papers, the panel and tutorial presenters, the Program Committee
members and the external reviewers for their excellent work. We thank the
Track Chairs for their significant contribution: Brian Athey, Joyce Mitchell,
Joyce Niland, Raul Rabadan, Indra Neil Sarkar, and Richard Scheuerman.
Special thanks go to all the AMIA organizers, including Jeff Williamson and
Edward H Shortliffe, MD, PhD. Finally, we are grateful for help from Isobel
Peters from BioMed Central in putting this supplement together.
The conference Website for the 2010 AMIA Summit on Translational
Bioinformatics is at: http://summit2010.amia.org/
This article has been published as part of BMC Bioinformatics Volume 11
Supplement 9, 2010: Selected Proceedings of the 2010 AMIA Summit on
Translational Bioinformatics. The full contents of the supplement are
available online at http://www.biomedcentral.com/1471-2105/11?issue=S9.
Author details
1Department of Pediatrics and Computation Institute, The University of
Chicago, Chicago, IL, USA.
2Department of Pediatrics, Department of Medical
Education and Biomedical Informatics, University of Washington, Seattle, WA,
USA.
Authors’ contributions
Both authors wrote and approved the manuscript. Mendonça was a
member of the Scientific Program Committee for the 2010 AMIA Summit on
Translational Bioinformatics and the Guest Editor for this special issue;
Tarczy-Hornoch was the Chair of the Scientific Program Committee for the
2010 AMIA Summit on Translational Bioinformatics.
Competing interests
The authors declare that they have no competing interests.
Published: 28 October 2010
References
1. Chang HH, McGeachie M, Alterovitz G, Ramoni MF: Mapping transcription
mechanisms from multimodal genomic data. BMC Bioinformatics 2010,
11(Suppl 9):S2.
2. Payne PRO, Huang K, Keen-Circle K, Kundu A, Zhang J, Borlawsky TB: Multi-
dimensional discovery of biomarker and phenotype complexes. BMC
Bioinformatics 2010, 11(Suppl 9):S3.
3. Chen DP, Dudley JT, Butte AJ: Latent physiological factors of comples
human diseases revealed by independent component analysis of
clinarrays. BMC Bioinformatics 2010, 11(Suppl 9):S4.
4. Zhang J, Ding L, Xiang Y, Keen-Circle K, Borlawsky TB, Ozer HG, Jin R,
Payne P, Huang K: Using gene co-expression network analysis to predict
biomarkers for chronic lymphocytic leukemia. BMC Bioinformatics 2010,
11(Suppl 9):S5.
5. Morgan AA, Khatri P, Jones RH, Sarwal MM, Butte AJ: Comparison of
multiplex meta analysis techniques for understanding the acute
rejection of solid organ transplants. BMC Bioinformatics 2010, 11(Suppl 9):
S6.
6. Harpaz R, Chase HS, Friedman C: Mining multi-item drug adverse effect
associations in spontaneous reporting systems. BMC Bioinformatics 2010,
11(Suppl 9):S7.
7. Lacson R, Mbagwu M, Yousif H, Ohno-Machado L: Assessing the quality of
annotations in asthma gene expression experiments. BMC Bioinformatics
2010, 11(Suppl 9):S8.
Mendonça and Tarczy-Hornoch BMC Bioinformatics 2010, 11(Suppl 9):S1
http://www.biomedcentral.com/1471-2105/11/S9/S1
Page 3 of 48. Tatonetti NP, Dudley JT, Sagreiya H, Butte AJ, Altman RB: An integrative
method for scoring candidate genes from association studies:
applications to warfarin dosing. BMC Bioinformatics 2010, 11(Suppl 9):S9.
9. Overby CL, Tarczy-Hornoch P, Hoath JI, Kalet IJ, Veenstra DL: Feasibility of
incorporating genomic knowledge into electronic medical records for
pharmacogenomic clinical decision making. BMC Bioinformatics 2010,
11(Suppl 9):S10.
10. Yang X, Lee Y, Huang Y, Chen JL, Xing R, Lussier YA: Stromal
microenvironment processes unveiled by biological component analysis
of gene expression in xenograft tumor models. BMC Bioinformatics 2010,
11(Suppl 9):S11.
11. Rouchka E, Montoya D, Stribinskis V, Ramos K, Kalbfleisch T: Assessment of
genetic variation for the LINE-1 retrotransposon from next generation
sequence data. BMC Bioinformatics 2010, 11(Suppl 9):S12.
doi:10.1186/1471-2105-11-S9-S1
Cite this article as: Mendonça and Tarczy-Hornoch: Selected proceedings
of the 2010 Summit on Translational Bioinformatics. BMC Bioinformatics
2010 11(Suppl 9):S1.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Mendonça and Tarczy-Hornoch BMC Bioinformatics 2010, 11(Suppl 9):S1
http://www.biomedcentral.com/1471-2105/11/S9/S1
Page 4 of 4